Intrinsic Value of S&P & Nasdaq Contact Us

Tarsus Pharmaceuticals, Inc. TARS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$89.00
+20.6%

Tarsus Pharmaceuticals, Inc. (TARS) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ALDX, CNTA, CNTB, DSGN, ELDN and others.

TARS has a market capitalization of $3.14B, compared to an average peer market cap of $870.41M. TARS is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message